+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine"

Microcarriers - Global Strategic Business Report - Product Thumbnail Image

Microcarriers - Global Strategic Business Report

  • Report
  • February 2026
  • 193 Pages
  • Global
From
Microarray Analysis - Global Strategic Business Report - Product Thumbnail Image

Microarray Analysis - Global Strategic Business Report

  • Report
  • February 2026
  • 179 Pages
  • Global
From
NGS-Based RNA-Sequencing - Global Strategic Business Report - Product Thumbnail Image

NGS-Based RNA-Sequencing - Global Strategic Business Report

  • Report
  • February 2026
  • 196 Pages
  • Global
From
Protein Labeling - Global Strategic Business Report - Product Thumbnail Image

Protein Labeling - Global Strategic Business Report

  • Report
  • February 2026
  • 179 Pages
  • Global
From
Glycomics / Glycobiology - Global Strategic Business Report - Product Thumbnail Image

Glycomics / Glycobiology - Global Strategic Business Report

  • Report
  • February 2026
  • 249 Pages
  • Global
From
Gene Panel - Global Strategic Business Report - Product Thumbnail Image

Gene Panel - Global Strategic Business Report

  • Report
  • February 2026
  • 197 Pages
  • Global
From
3D Cell Culture - Global Strategic Business Report - Product Thumbnail Image

3D Cell Culture - Global Strategic Business Report

  • Report
  • February 2026
  • 150 Pages
  • Global
From
Cell Harvesting - Global Strategic Business Report - Product Thumbnail Image

Cell Harvesting - Global Strategic Business Report

  • Report
  • February 2026
  • 306 Pages
  • Global
From
Cell Dissociation - Global Strategic Business Report - Product Thumbnail Image

Cell Dissociation - Global Strategic Business Report

  • Report
  • February 2026
  • 193 Pages
  • Global
From
Cell Counting - Global Strategic Business Report - Product Thumbnail Image

Cell Counting - Global Strategic Business Report

  • Report
  • February 2026
  • 182 Pages
  • Global
From
Cell Based Assays - Global Strategic Business Report - Product Thumbnail Image

Cell Based Assays - Global Strategic Business Report

  • Report
  • February 2026
  • 194 Pages
  • Global
From
Bioburden Testing - Global Strategic Business Report - Product Thumbnail Image

Bioburden Testing - Global Strategic Business Report

  • Report
  • February 2026
  • 173 Pages
  • Global
From
Competent Cells - Global Strategic Business Report - Product Thumbnail Image

Competent Cells - Global Strategic Business Report

  • Report
  • February 2026
  • 196 Pages
  • Global
From
Biopreservation - Global Strategic Business Report - Product Thumbnail Image

Biopreservation - Global Strategic Business Report

  • Report
  • February 2026
  • 178 Pages
  • Global
From
From
Biobanks - Global Strategic Business Report - Product Thumbnail Image

Biobanks - Global Strategic Business Report

  • Report
  • February 2026
  • 402 Pages
  • Global
From
Biophotonics - Global Strategic Business Report - Product Thumbnail Image

Biophotonics - Global Strategic Business Report

  • Report
  • February 2026
  • 214 Pages
  • Global
From
BioImaging Technologies - Global Strategic Business Report - Product Thumbnail Image

BioImaging Technologies - Global Strategic Business Report

  • Report
  • February 2026
  • 174 Pages
  • Global
From
Molecular Cytogenetics - Global Strategic Business Report - Product Thumbnail Image

Molecular Cytogenetics - Global Strategic Business Report

  • Report
  • February 2026
  • 657 Pages
  • Global
From
Metabolomics - Global Strategic Business Report - Product Thumbnail Image

Metabolomics - Global Strategic Business Report

  • Report
  • February 2026
  • 415 Pages
  • Global
From
Loading Indicator

Personalized Medicine is a form of biotechnology that focuses on tailoring medical treatments to the individual needs of a patient. It is based on the idea that each person's genetic makeup, lifestyle, and environment can affect their response to a particular treatment. This approach to medicine has the potential to improve patient outcomes and reduce healthcare costs. Personalized Medicine utilizes a variety of technologies, such as genomics, proteomics, and metabolomics, to identify and analyze a patient's unique characteristics. This information is then used to develop treatments that are tailored to the individual's needs. Additionally, personalized medicine can be used to identify and monitor diseases, predict drug responses, and develop new treatments. Some companies in the Personalized Medicine market include 23andMe, Illumina, and Thermo Fisher Scientific. Show Less Read more